Biotechnology
Company Overview of Emerillon Therapeutics Inc.
Company Overview
Emerillon Therapeutics, Inc., a biotechnology company, engages in the discovery and development of genomics-based drugs for infectious diseases. The company, through its recombinant congenic strains (RCS) mouse platform technology, discovers and develops drugs for human complex diseases. Its RCS mouse platform focuses on identifying drug targets in the fields of pain, atherosclerosis, osteoporosis, and epilepsy. Emerillon Therapeutics also offers contract services, such as mutation detection using dHPLC, mouse genotyping, and speed congenesis. The company was founded in 2003 and is based in Montréal, Canada.
416 de Maisonneuve West
Suite 1000
Montréal, QC H3A 1L2
Canada
Founded in 2003
Phone:
514-985-0306
Fax:
514-985-0012
Key Executives for Emerillon Therapeutics Inc.
Similar Private Companies By Industry
| Company Name | Region |
| Dragon Pharmaceutical Inc. | Americas |
| Sherfam Inc. | Americas |
| Virocell, Inc. | Americas |
| ID Biomedical Corporation of Quebec | Americas |
| Kerr Investment Holding Corp. | Americas |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||

Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
- Orlando, FL | Consult SoftPosted: May 22
Sponsored Financial Commentaries
Sponsored Links
To contact Emerillon Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








